| |
§Cryptogenic HCC (n = 18)
|
HBV-HCC (n = 36)
|
*p
|
HCV-HCC (n = 36)
|
**p
|
¶ ALC-HCC
|
***p
|
|---|
| | | | | | |
(n = 23)
| |
|---|
|
Age (yr) †
|
70.3 ± 10.6
|
67.4 ± 9.1
|
0.201
|
69.0 ± 8.8
|
0.646
|
67.7 ± 9.6
|
0.510
|
|
Gender, male††
|
9 (50.0)
|
9 (50.0)
|
1.000
|
9 (50.0)
|
1.000
|
18 (78.3)
|
0.097
|
|
BMI (kg/m2) †
|
24.7 ± 3.0
|
23.3 ± 3.1
|
0.196
|
22.8 ± 3.2
|
0.050
|
24.5 ± 4.9
|
0.415
|
|
VFA (cm2) †
|
134.4 ± 53.9
|
100.0 ± 51.3
|
0.037
|
105.0 ± 51.1
|
0.034
|
136.9 ± 64.9
|
0.599
|
|
Liver attenuation (HU) †
|
54.3 ± 5.5
|
53.7 ± 5.8
|
0.533
|
53.5 ± 6.7
|
0.441
|
50.7 ± 8.3
|
0172
|
|
Spleen attenuation (HU) †
|
44.0 ± 4.5
|
43.7 ± 4.0
|
0.263
|
45.0 ± 3.8
|
0.734
|
44.0 ± 5.0
|
0.743
|
|
Liver/Spleen ratio†
|
1.24 ± 0.14
|
1.23 ± 0.14
|
0.854
|
1.20 ± 0.14
|
0.419
|
1.15 ± 0.14
|
0.066
|
- †Expressed as the mean ± standard deviation. ††Expressed as the number of subjects (%). Values in bold, statistically significant (p < 0.05).
- § Available data in 18 patients. Eighteen patients with cryptogenic HCC were matched for age and sex (1:2 ratio) with HBV-HCC or HCV-HCC patients.
- ¶ Of 55 ALC-HCC, VFA was measured in 23 patients. ALC-HCC patients did not match with regard to age and sex with cryptogenic-HCC patients because they were mostly of male gender and because the sample sizes of each subgroup were small.
-
HU, Hounsfield unit; VFA, Visceral fat accumulation; BMI, Body mass index.
- *p: Cryptogenic HCC vs. HBV-HCC.
- **p: Cryptogenic HCC vs. HCV-HCC.
- ***p: Cryptogenic HCC vs. ALC-HCC.
